Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantCarrie E. Ryan, Davendra Sohal, Jacob T. Lambdin et al.|Annals of Surgical Oncology|2022Cited by 3